Using MoCA-Thai to evaluate cognitive impairment in patients with schizophrenia

Journal of the Medical Association of Thailand

Volumn 96, Issue 7, 2013, Pages 860-865

  Arunpongpaisal, Suwanna ^a   Sangsirilak, Akekalak ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b Psychiatric Unit Yasothron Hospital   (Thailand)

Author keywords

Cognitive impairment; MoCA Thai; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; NEUROLEPTIC AGENT;

ADULT; ARTICLE; COGNITION; COGNITIVE DEFECT; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIAGNOSTIC TEST; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTREAL COGNITIVE ASSESSMENT THAI VERSION TEST; PARANOIA; PATIENT EDUCATION; PREVALENCE; SCHIZOPHRENIA; COGNITION DISORDERS; MIDDLE AGED; PSYCHOLOGIC TEST; PSYCHOLOGY; SCHIZOPHRENIA, PARANOID; THAILAND;

ADULT; ANTIPSYCHOTIC AGENTS; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; SCHIZOPHRENIA, PARANOID; THAILAND;

EID: 84880051877     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bozikas VP, Kosmidis MH, Peltekis A, Giannakou M, Nimatoudis I, Karavatos A, et al. Sex differences in neuropsychological functioning among schizophrenia patients. Aust N Z J Psychiatry 2010; 44: 333-341.
2. Ngoma M, Vansteelandt K, Delespaul P, Krabbendam L, Miezi SM, Peuskens J. Cognitive deficits in nonaffective functional psychoses: a study in the Democratic Republic of Congo. Psychiatry Res 2010; 180: 86-92.
3. Sponheim SR, Jung RE, Seidman LJ, Mesholam-Gately RI, Manoach DS, O'Leary DS, et al. Cognitive deficits in recent-onset and chronic schizophrenia. J Psychiatr Res 2010; 44: 421-428.
4. Sostaric M, Zalar B. The overlap of cognitive impairment in depression and schizophrenia: a comparative study. Psychiatr Danub 2011; 23: 251-256.
5. Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophr Bull 1999; 25: 173-182.
6. Aleman A, Hijman R, de Haan EH, Kahn RS. Memory impairment in schizophrenia: a meta-analysis. Am J Psychiatry 1999; 156: 1358-1366.
7. Mohamed S, Paulsen JS, O'Leary D, Arndt S, Andreasen N. Generalized cognitive deficits in schizophrenia: a study of first-episode patients. Arch Gen Psychiatry 1999; 56: 749-754.
8. Stip E, Caron J, Renaud S, Pampoulova T, Lecomte Y. Exploring cognitive complaints in schizophrenia: the subjective scale to investigate cognition in schizophrenia. Compr Psychiatry 2003; 44: 331-340.
9. Hill SK, Beers SR, Kmiec JA, Keshavan MS, Sweeney JA. Impairment of verbal memory and learning in antipsychotic-naive patients with first-episode schizophrenia. Schizophr Res 2004; 68: 127-136.
10. Han X, Yang L, Cheng Z, Zhang T, Yuan YB, Yu X. Neurocognitive performance in the patients with first-episode schizophrenia and their independent first-degree relatives: a cross-sectional study. Beijing Da Xue Xue Bao 2010; 42: 681-686.
11. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699.
12. Amdur MA. Cognitive impairment in mental illness: an SSA blind spot? Psychiatr Serv 2011; 62: 682.
13. Tangwongchai S, Charernboon T, Phanasathit M, Akkayagorn L, Hemrungrojn S, Phanthumchinda K, Nasreddine ZS. The Validity of Thai version of The Montreal Cognitive Assessment (MoCA-T) [abstract]. Dement Neuropsychol 2009; 3: 172.
14. Gil D, Bengochea R, Arrieta M, Lastra I, Sanchez R, Alvarez A, et al. Use of Barcelona Test for cognitive assessment of patients with schizophrenia. Actas Esp Psiquiatr 2008; 36: 337-344.
15. Squibb SM. EJ, Palmer BW., Paulsen JS., Jeste DV., Heaton RK. The Prevalence of Specific Cognitive Impairments in Schizophrenia. Abstract from the Sixteenth Annual Meeting, New Orleans, Louisiana, October 30-November 2, 1996. Arch Clin Neuropsychol 1997; 12: 409.
16. Driesen NR, Leung HC, Calhoun VD, Constable RT, Gueorguieva R, Hoffman R, et al. Impairment of working memory maintenance and response in schizophrenia: functional magnetic resonance imaging evidence. Biol Psychiatry 2008; 64: 1026-1034.
17. Brazo P, Delamillieure P, Morello R, Halbecq I, Marie RM, Dollfus S. Impairments of executive/ attentional functions in schizophrenia with primary and secondary negative symptoms. Psychiatry Res 2005; 133: 45-55.
18. Rajji TK, Mulsant BH. Nature and course of cognitive function in late-life schizophrenia: a systematic review. Schizophr Res 2008; 102: 122-140.
19. Bozikas VP, Kosmidis MH, Kiosseoglou G, Karavatos A. Neuropsychological profile of cognitively impaired patients with schizophrenia. Compr Psychiatry 2006; 47: 136-143.
20. Karlsgodt KH, van Erp TG, Poldrack RA, Bearden CE, Nuechterlein KH, Cannon TD. Diffusion tensor imaging of the superior longitudinal fasciculus and working memory in recent-onset schizophrenia. Biol Psychiatry 2008; 63: 512-518.
21. Perlstein WM, Carter CS, Noll DC, Cohen JD. Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia. Am J Psychiatry 2001; 158: 1105-1113.
22. Douaud G, Smith S, Jenkinson M, Behrens T, Johansen-Berg H, Vickers J, et al. Anatomically related grey and white matter abnormalities in adolescent-onset schizophrenia. Brain 2007; 130: 2375-2386.
23. Morrens M, Hulstijn W, Sabbe B. The effects of atypical and conventional antipsychotics on reduced processing speed and psychomotor slowing in schizophrenia: a cross-sectional exploratory study. Clin Ther 2008; 30: 684-692.
24. Kucharska-Pietura K, Tylec A, Czernikiewicz A, Mortimer A. Attentional and emotional functioning in schizophrenia patients treated with conventional and atypical antipsychotic drugs. Med Sci Monit 2012; 18: CR44-CR49.
25. Remillard S, Pourcher E, Cohen H. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia. J Int Neuropsychol Soc 2008; 14: 110-118.